Patient advocate startup Solace is set to be valued at over $300 million in new funding round from Menlo Ventures
Juan Moyano/Getty Images Solace is raising a Series B funding round led by Menlo Ventures, Business Insider has learned. Solace connects patients with healthcare advocates to simplify tasks like scheduling and payments. Sources with knowledge of the deal said the new round values Solace at more than $300 million. Buzzy healthcare startup Solace just raised a fresh round of funding led by VC firm Menlo Ventures , Business Insider has learned. Solace, which connects patients with healthcare advocates, is raising a Series B funding round that values the startup at over $300 million, according to multiple sources with knowledge of the deal. These sources said Solace was seeking to raise around $40 million in the Series B round. Solace didn't respond to requests for comment for this story. A Menlo Ventures spokesperson said the firm doesn't comment on rumors or speculation. Cofounders Jeremy Gurewitz, CEO, and Sara Sargent, chief product officer, launched Solace in 202...